NEXGEL, Inc. (NASDAQ:NXGL) Director Sells $10,110.00 in Stock

NEXGEL, Inc. (NASDAQ:NXGL) Director Scott Robert Henry sold 3,000 shares of the stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $3.37, for a total value of $10,110.00. Following the transaction, the director now owns 141,553 shares in the company, valued at $477,033.61. This trade represents a 2.08 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Scott Robert Henry also recently made the following trade(s):

• On Friday, December 20th, Scott Robert Henry sold 3,000 shares of NEXGEL stock. The shares were sold at an average price of $4.64, for a total transaction of $13,920.00.

NEXGEL Price Performance

NXGL opened at $3.39 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.51 and a quick ratio of 0.93. The stock’s 50 day simple moving average is $3.74 and its 200 day simple moving average is $3.01. The firm has a market cap of $23.02 million, a price-to-earnings ratio of -5.84 and a beta of 0.61. NEXGEL, Inc. has a 1 year low of $1.84 and a 1 year high of $5.10.

Institutional Inflows and Outflows

An institutional investor recently raised its position in NEXGEL stock. Northeast Financial Group Inc. boosted its stake in NEXGEL, Inc. (NASDAQ:NXGL) by 168.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,848 shares of the company’s stock after acquiring an additional 20,000 shares during the period. Northeast Financial Group Inc. owned 0.50% of NEXGEL worth $82,000 at the end of the most recent reporting period. 2.21% of the stock is owned by institutional investors and hedge funds.

NEXGEL Company Profile

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.